CD274 and gastric neoplasm: Consistent with the results from PET imaging and biodistribution, the fluorescence intensity of PD-L1 was higher in samples incubated with fluorescently labeled avelumab compared to atezolizumab in two different gastric tumor samples (Figure 3D).